DOI:
10.1055/s-00000125
Senologie - Zeitschrift für Mammadiagnostik und -therapie
LinksClose Window
References
Hortobagyi GN, Van Poznak C, Harker WG. et al.
Continued Treatment Effect of Zoledronic Acid Dosing Every 12 vs. 4 Weeks in Women With Breast Cancer Metastatic to Bone: The OPTIMIZE‑2 Randomized Clinical Trial.
JAMA Oncol 2017;
3: 906-912
We do not assume any responsibility for the contents of the web pages of other providers.